The entire world is holding its breath for a COVID-19 vaccine. More than 165 vaccines are under development around the world, and four companies — AstraZeneca, Johnson & Johnson, Moderna Therapeutics, and Pfizer — have expressed optimism that their products could be ready for widespread distribution in late 2020 or early 2021. Yet, the fastest vaccine ever produced took four years, and on average vaccine development is a 10-year process.
Can the vaccine development process be drastically shortened without compromising safety? How will a market-ready vaccine be equitably distributed? What happens if a significant percentage of Americans don’t want to be vaccinated?
Susan R. Bailey, M.D.
President, American Medical Association
Dan Moulthrop
CEO, The City Club of Cleveland
